We’re pleased to share this letter published in the BMJ by Dr John Kelly, ST5 in infectious diseases and medical microbiology here at RIDU. Please find an excerpt of this incredibly important letter, and a link to the full article below

There are good reasons to suspect that the epidemiology of injecting drug use and its potential harms may have changed as a result of covid-19. These may be anecdotally observed by clinicians, although most complications are not captured by routine surveillance. Some studies have examined the impact of the pandemic on drug use and services in the UK,7 but detailed analysis of its consequences is lacking. The risks of failing to understand these changes may compound the political and social neglect that these people experience, as a low priority for decision makers. – Dr John Kelly

The full article can be found here: https://www.bmj.com/content/376/bmj.o476